Treasury Pivot
Prenetics Global Limited ($PRE) has officially suspended its Bitcoin acquisition strategy, ending a short-lived corporate treasury experiment to redirect capital toward its consumer health subsidiary, IM8. In a Form 6-K filing submitted to the SEC today, the company disclosed it ceased daily Bitcoin purchases on December 4, 2025.
The health sciences firm will retain its existing hoard of 510 BTC (worth approximately $44.8 million at current prices) but has ruled out future acquisitions. The decision marks a sharp reversal from the “dual-pronged” strategy adopted earlier this year, which saw the company raising $48 million in October specifically to fuel both IM8’s expansion and Bitcoin accumulation.
The Beckham Effect
The capital flight from crypto is flowing directly into IM8, a longevity brand co-founded by David Beckham. Prenetics cited “explosive” growth as the primary catalyst, reporting that IM8 surpassed $100 million in Annualized Recurring Revenue (ARR) within 11 months of launch. Management projects revenue between $180 million and $200 million for fiscal year 2026.
The Board and management team unanimously agreed that the most promising path to creating significant, sustainable shareholder value is to devote our undivided attention to this once-in-a-generation opportunity. Danny Yeung, CEO of Prenetics
Market Reaction
Investors appeared indifferent to the strategic U-turn. $PRE shares traded flat at $16.88 in pre-market action, while Bitcoin hovered around $88,000. The move highlights the friction between aggressive corporate treasury plays and the capital demands of hyper-growth operational segments; when a core business line essentially doubles its revenue run rate in a year, speculative asset accumulation often takes a back seat.
